Unexpected quality problems in pharmaceutical manufacturing require a reliable root cause analysis as well as quality and safety assessment followed by the definition of preventive measures to avoid such incidents.
Find out what this means in detail in our HWI-blog by Dr Sandra Huertgen.
30 years ago: On January 8th, 1991, the company was founded by Dr. Stefan Wissel and Prof. Dr. Hanns Häberlein. The two university friends created the name HWI from the first letters of their last names.
As of January 1st, 2021, Dr Frank Böttcher will be appointed to the management team of HWI pharma services GmbH and will strengthen the current management team of Dr Stefan Wissel and Dr Melanie Kerst.
The term "nano" seems to be omnipresent. These are particles that are smaller than a millionth of a meter in diameter. As tiny as they are, nanoparticles offer great potential for humans, nature and technology.
What role nanoparticles play in the pharmaceutical industry can be read in our latest HWI-blog von Philipp Wissel.